Search Results

You are looking at 21 - 30 of 131 items for :

  • "symptom burden" x
  • Refine by Access: All x
Clear All
Full access

Rehabilitation in Oncology Care Guidelines: A Gap Analysis

Cristina Kline-Quiroz, Cody Andrews, Patrick Martone, James Thomas Pastrnak, Katherine Power, Sean R. Smith, and Eric Wisotzky

, 11 and reduce symptom burden from other impairments. 12 , 13 Furthermore, a decline in function and ability to perform activities of daily living is associated with greater mortality, suggesting a role for rehabilitation in cancer care beyond

Full access

Group Coping Intervention in Patients With Chronic Graft-Versus-Host Disease: A Pilot Randomized Clinical Trial

Ashley M. Nelson, Daniel Yang, Annemarie D. Jagielo, Jennifer D’Alotto, Cathleen Poliquin, Dustin J. Rabideau, Katherine G. Cronin, Richard A. Newcomb, Yi-Bin Chen, Zachariah DeFilipp, Joseph A. Greer, Areej El-Jawahri, and Lara Traeger

hypothesized that the Horizons Program would be feasible based on enrollment, attendance, and retention (primary outcomes). We also explored intervention effects on QoL, symptom burden, and anxiety and depression symptoms (secondary outcomes), as well as on

Full access

Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer

Joseph A. Greer, Jamie M. Jacobs, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Molly E. Ream, Emily A. Walsh, Joanne Buzaglo, Alona Muzikansky, Inga T. Lennes, Steven A. Safren, William F. Pirl, and Jennifer S. Temel

(MMAS-4), symptom burden, QoL, satisfaction with treatment, and healthcare utilization did not differ significantly between groups ( Table 2 ). Table 2. Study Group Differences in Primary and Secondary Outcomes Moderation Effects on Adherence Outcome As

Full access

Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study

Jesse D. Troy, Carlos M. de Castro, Mary Ruth Pupa, Greg P. Samsa, Amy P. Abernethy, and Thomas W. LeBlanc

-reported distress in ambulatory patients with MDS visiting a Comprehensive Cancer Center. First, these patients have a relatively high burden of distress, with physical symptoms representing the most frequently reported issue, and a greater overall symptom burden in

Full access

Priority Rankings of Patient-Reported Outcomes for Pancreatic Ductal Adenocarcinoma: A Comparison of Patient and Physician Perspectives

Michelle Guan, Gillian Gresham, Arvind Shinde, Isaac Lapite, Jun Gong, Veronica R. Placencio-Hickok, Christopher B. Forrest, and Andrew E. Hendifar

care, the severity of treatment-related impairments that later develop may be reduced, which is especially relevant to a high–symptom burden disease such as PDAC. Further research on the feasibility of incorporating PROs in pancreatic cancer care is

Full access

Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-Term Patient Outcomes

Eva Battaglini, David Goldstein, Peter Grimison, Susan McCullough, Phil Mendoza-Jones, and Susanna B. Park

validated measures to assess CIPN, QoL, and physical activity. We aimed to investigate the impacts associated with CIPN symptom burden on the lives of cancer survivors across a range of domains, examining symptoms over time and interactions with other

Full access

HSR24-124: Determinants of Quality of Life and Optimism in Patients With EGFR Mutated Advanced Non–Small Cell Lung Cancer

Elizabeth Marrett, Shaloo Gupta, Kushal Modi, Song Li, Jillian Rowen, and Jackie Kwong

associated with Asian race, having a caregiver, and higher NSCLC symptom burden (all P <.05). Conclusion: Efficacious treatments that improve patient expectations and satisfaction with therapy, reduce NSCLC symptoms, and prolong progression-free survival

Full access

BPI22-020: Better Together: Why Palliative Care Should be Incorporated Early in Patients With Advanced Head and Neck Cancer

Vishal Kapadia, Elisa Griswold, Kelley Newcomer, Brittny Tillman, Jane Mwangi, and Stephanie Terauchi

Background : Advanced head and neck cancers often necessitate intensive treatment regimens in pursuit of a cure. These cancers and their treatments frequently lead to significant symptom burden, impacting many patients’ overall quality of life

Full access

QIM21-084: Perceived Needs and Patient Satisfaction of Psychosocial Distress Screening and Management in Inpatient Hematology Oncology Specialty Care

Chao-Hui Sylvia Huang, Jennifer K. Anderson, Jasmine A. Boykin, Jasmine K. Vickers, Heather Forbes, Kellie L. Flood, Lisle M. Nabell, and Kelly N. Godby

strategies to manage anxiety or depression. Barriers to receive counseling services include physical symptom burden such as pain and fatigue, medical procedures, and inadequate psychosocial care staffing. Findings revealed high perceived needs and patient

Full access

HSR24-166: Implementation of an Integrated Supportive Care Medicine Consultation Service Within a Gastrointestinal Cancer Clinic: Timeliness of Referrals and Patient Access

Dena Berhan, Nicole Nardella, Adrianna Oraiqat, Denny Lu, Sarah Goodchild, Terry Gruchow, Young Chang, Sahana Rajasekhara, and Pamela Hodul

-narcotic pain management remained the same. GI malignancies frequently present with advanced cancers and high symptom burden. Improved access to SCM has been associated with improved quality of life (QOL) and increased survival. (Temel et al, 2010, 2017) Here we